{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:10:35Z","timestamp":1790723435779,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.122860","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:14:40Z","timestamp":1790608480000},"page":"122860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analytical standardization and inter-platform harmonization of immunoassay-based biomarkers in atopic dermatitis: Challenges and a roadmap for clinical laboratory implementation"],"prefix":"10.1016","volume":"594","author":[{"given":"Mansur","family":"Tolibov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Khamidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobur","family":"Toirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iroda","family":"Nurmatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhrorbek","family":"Abdurakhmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Opolovnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khamza","family":"Trobov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bjd\/ljad339","article-title":"Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study","volume":"190","author":"Tian","year":"2024","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.cca.2026.122860_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-3038.2004.00160.x","article-title":"Natural history of atopic dermatitis and its relationship to serum total immunoglobulin E in a population-based birth cohort study","volume":"15","author":"Perkin","year":"2004","journal-title":"Pediatr. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.25259\/IJSA_37_2024","article-title":"A review of comorbidities in atopic dermatitis","volume":"3","author":"Sengkioun","year":"2024","journal-title":"Indian J. Skin Allergy"},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","article-title":"Comorbidities of atopic dermatitis\u2014what does the evidence say?","volume":"151","author":"Thyssen","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0025","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bjd.15641","article-title":"Severity strata for eczema area and severity index (EASI), modified EASI, scoring atopic dermatitis (SCORAD), objective SCORAD, atopic dermatitis severity index and body surface area in adolescents and adults with atopic dermatitis","volume":"177","author":"Chopra","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"31","key":"10.1016\/j.cca.2026.122860_bb0030","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e223","article-title":"Systemic inflammatory proteomic biomarkers in atopic dermatitis: exploring potential indicators for disease severity","volume":"39","author":"Woo","year":"2024","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.cca.2026.122860_bb0035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaci.2017.03.023","article-title":"Moving toward endotypes in atopic dermatitis: identification of patient clusters based on serum biomarker analysis","volume":"140","author":"Thijs","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2020.04.062","article-title":"Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers","volume":"147","author":"Bakker","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cca.2026.122860_bb0045","article-title":"Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: significance and limitations in the new treatment era","volume":"5","author":"Kataoka","year":"2024","journal-title":"Front. Allergy"},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/all.14080","article-title":"Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: first clinical and biomarker results from the BioDay registry","volume":"75","author":"Ari\u00ebns","year":"2020","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.cca.2026.122860_bb0055","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1365-2222.2005.02353.x","article-title":"The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis","volume":"35","author":"Mitsuishi","year":"2005","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40257-024-00913-9","article-title":"Biomarkers in atopic dermatitis: a review of the role of IL-13 and the impact of Tralokinumab treatment","volume":"26","author":"Gorelick","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.cca.2026.122860_bb0065","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jaci.2017.12.991","article-title":"Serum biomarker profiles suggest that atopic dermatitis is a systemic disease","volume":"141","author":"Thijs","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09207-z","article-title":"The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins","volume":"7","author":"Brunner","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0075","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-025-59340-x","article-title":"An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis","volume":"16","author":"Fukushima-Nomura","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.122860_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01768","article-title":"Tape-strip proteomic profiling of atopic dermatitis on Dupilumab identifies minimally invasive biomarkers","volume":"11","author":"He","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2026.122860_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13413","article-title":"Development of a novel microneedle platform for biomarker assessment of atopic dermatitis patients","volume":"29","author":"Lee","year":"2023","journal-title":"Skin Res. Technol."},{"issue":"11","key":"10.1016\/j.cca.2026.122860_bb0090","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/exd.14389","article-title":"Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease","volume":"30","author":"Sims","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.cca.2026.122860_bb0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.cca.2026.122860_bb0100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/bjd.17088","article-title":"Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis","volume":"180","author":"McAleer","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cca.2026.122860_bb0105","article-title":"Comparison of highly sensitive, multiplex immunoassay platforms for streamlined clinical cytokine quantification","volume":"537","author":"Zetlen","year":"2025","journal-title":"J. Immunol. Methods"},{"issue":"7","key":"10.1016\/j.cca.2026.122860_bb0110","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4049\/jimmunol.2300729","article-title":"Cross-platform comparison of highly-sensitive immunoassays for inflammatory markers in a COVID-19 cohort","volume":"212","author":"Abe","year":"2024","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2026.122860_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70042","article-title":"Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: retrospective research of clinical practice, biomarkers, and pathology","volume":"30","author":"Lin","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.cca.2026.122860_bb0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/10408363.2015.1116851","article-title":"Harmonization in laboratory medicine: requests, samples, measurements and reports","volume":"53","author":"Plebani","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.122860_bb0125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1515\/cclm-2015-0067","article-title":"Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine","volume":"53","author":"Sandberg","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0130","article-title":"Harmonization of immunoassays for biomarkers in diabetes mellitus","volume":"37","author":"Weykamp","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"11","key":"10.1016\/j.cca.2026.122860_bb0135","first-page":"1467","article-title":"IFCC education and clinical practice committee approved recommendations on cardiac troponin standardization","volume":"58","author":"Apple","year":"2012","journal-title":"Clin. Chem."},{"issue":"4\u20135","key":"10.1016\/j.cca.2026.122860_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinbiochem.2008.09.098","article-title":"Traceability as a unique tool to improve standardization in laboratory medicine","volume":"42","author":"Panteghini","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.122860_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120634","article-title":"Immunoassay-based biomarkers in atopic dermatitis","volume":"579","author":"Orayj","year":"2026","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0150","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/all.15153","article-title":"Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies","volume":"77","author":"Andersson","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaad.2022.12.050","article-title":"Proteomic characterization of atopic dermatitis blood from infancy to adulthood","volume":"88","author":"Del Duca","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.cca.2026.122860_bb0160","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/intimm\/dxy015","article-title":"Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers","volume":"30","author":"Nomura","year":"2018","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0165","first-page":"105","article-title":"Interferences in immunoassay","volume":"25","author":"Tate","year":"2004","journal-title":"Clin. Biochem. Rev."},{"issue":"7","key":"10.1016\/j.cca.2026.122860_bb0170","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s13555-024-01193-1","article-title":"Biomarkers in atopic dermatitis","volume":"14","author":"Libon","year":"2024","journal-title":"Dermatol. Ther. (Heidelb.)"},{"issue":"18","key":"10.1016\/j.cca.2026.122860_bb0175","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/diagnostics13182935","article-title":"Analytical performance of a novel latex turbidimetric immunoassay, Nanopia TARC, for TARC\/CCL17 measurement","volume":"13","author":"Koga","year":"2023","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0180","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2021.06.029","article-title":"Unraveling heterogeneity in pediatric atopic dermatitis: identification of serum biomarker based patient clusters","volume":"149","author":"Bakker","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.cca.2026.122860_bb0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4158\/EP171761.RA","article-title":"BIOTIN interference with routine clinical immunoassays: understand the causes and mitigate the risks","volume":"23","author":"Samarasinghe","year":"2017","journal-title":"Endocr. Pract."},{"issue":"4","key":"10.1016\/j.cca.2026.122860_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cca.2026.122860_bb0200","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/cea.70082","article-title":"Complementary analysis of local and systemic effects of Dupilumab in Paediatric AD using tape strips and serum","volume":"55","author":"van der Rijst","year":"2025","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0205","doi-asserted-by":"crossref","first-page":"21895","DOI":"10.1038\/s41598-020-78943-6","article-title":"Cytokine concentration across the stratum corneum in atopic dermatitis and healthy controls","volume":"10","author":"Clausen","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.122860_bb0210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"18","key":"10.1016\/j.cca.2026.122860_bb0215","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1039\/C5AN01238D","article-title":"Single molecule array (Simoa) assay with optimal antibody pairs for cytokine detection in human serum samples","volume":"140","author":"Wilson","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.cca.2026.122860_bb0220","article-title":"Single molecule array ultra-sensitive cytokine assays in EDTA plasma are robust and clinically feasible","volume":"497","author":"Chang","year":"2021","journal-title":"J. Immunol. Methods"},{"issue":"12","key":"10.1016\/j.cca.2026.122860_bb0225","first-page":"1579","article-title":"Ultra-sensitive protein detection technologies and their use in clinical diagnostics","volume":"67","author":"Duffy","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.122860_bb0230","article-title":"Comparison of three multiplex immunoassays for biomarker analysis in stratum corneum tape strips","volume":"15","author":"van Doorn","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0235","first-page":"204","article-title":"Measurement of cytokines: the current landscape and future promise","volume":"62","author":"Padoan","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.122860_bb0240","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1515\/CCLM.2006.073","article-title":"Preanalytical variability: the dark side of the moon in laboratory testing","volume":"44","author":"Lippi","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.122860_bb0245","doi-asserted-by":"crossref","first-page":"e230074","DOI":"10.20945\/2359-4292-2023-0074","article-title":"Multiple immunoassay interference in a patient with falsely elevated calcitonin","volume":"68","author":"Unal","year":"2023","journal-title":"Arch. Endocrinol. Metab."},{"issue":"42","key":"10.1016\/j.cca.2026.122860_bb0250","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031267","article-title":"Exploratory analyses of biomarkers in blood and stratum corneum in patients with atopic dermatitis","volume":"101","author":"Maruyama","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0255","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1402a123","article-title":"Tape stripping \u2014 searching for minimally invasive biomarkers in atopic dermatitis","volume":"14","author":"Zysk","year":"2024","journal-title":"Dermatol. Pract. Concept."},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jdermsci.2020.10.011","article-title":"The stratum corneum transcriptome in atopic dermatitis can be assessed by tape stripping","volume":"101","author":"S\u00f8lberg","year":"2021","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0265","first-page":"1285","article-title":"Skin TARC\/CCL17 increase precedes the development of childhood atopic dermatitis","volume":"151","author":"Halling","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"15","key":"10.1016\/j.cca.2026.122860_bb0270","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1021\/acs.analchem.1c05470","article-title":"Non-invasive, topical sampling of potential, low-molecular weight, skin cancer biomarkers: a study on healthy volunteers","volume":"94","author":"Jankovskaja","year":"2022","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0275","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2230.1996.tb00120.x","article-title":"The sweat of patients with atopic dermatitis contains specific IgE antibodies to inhalant allergens","volume":"21","author":"Jung","year":"1996","journal-title":"Clin. Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.cca.2026.122860_bb0280","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2021.11.e42","article-title":"Squamous cell carcinoma antigens are sensitive biomarkers for atopic dermatitis in children and adolescents: a cross-sectional study","volume":"11","author":"Hirayama","year":"2021","journal-title":"Asia Pac. Allergy"},{"issue":"12","key":"10.1016\/j.cca.2026.122860_bb0285","first-page":"e415","article-title":"Guidelines for the management of atopic dermatitis 2021","volume":"48","author":"Japanese Dermatological Association","year":"2021","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0290","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2019.04.036","article-title":"The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease","volume":"81","author":"Brunner","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.cca.2026.122860_bb0295","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00011-020-01368-4","article-title":"The association between IL18, FOXP3 and IL13 genes polymorphisms and risk of allergic rhinitis: a meta-analysis","volume":"69","author":"Tang","year":"2020","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.cca.2026.122860_bb0300","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70137","article-title":"Elevated neutrophil, lymphocyte, and platelet counts as early biomarkers of preeclampsia risk: a retrospective cohort study","volume":"94","author":"Yao","year":"2025","journal-title":"Am. J. Reprod. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2026.122860_bb0305","first-page":"2249","article-title":"HOME (harmonizing outcome measures for eczema): a roadmap for harmonization of clinical outcomes in eczema","volume":"132","author":"Spuls","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cca.2026.122860_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157425","article-title":"Reversal of BCAA-driven inflammatory senescence by traditional herbal oil prevents atopic dermatitis relapse","volume":"148","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.cca.2026.122860_bb0315","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1515\/cclm-2017-0151","article-title":"Analytical performance specifications for external quality assessment \u2013 definitions and descriptions","volume":"55","author":"Jones","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.122860_bb0320","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/cclm-2022-1255","article-title":"Biological variation: recent developments and future challenges","volume":"61","author":"Sandberg","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.122860_bb0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jim.2013.09.012","article-title":"Implementation of good clinical laboratory practice (GCLP) guidelines within the external quality assurance program oversight laboratory (EQAPOL)","volume":"409","author":"DeNardo","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cca.2026.122860_bb0330","author":"Bio-Rad Laboratories"},{"key":"10.1016\/j.cca.2026.122860_bb0335","series-title":"Regulation (EU) 2017\/746 on in vitro diagnostic medical devices (IVDR)","first-page":"176","author":"European Parliament and Council","year":"2017"},{"issue":"28","key":"10.1016\/j.cca.2026.122860_bb0340","doi-asserted-by":"crossref","first-page":"2400595","DOI":"10.1002\/advs.202400595","article-title":"Revolutionary point-of-care wearable diagnostics for early disease detection and biomarker discovery through intelligent technologies","volume":"11","author":"Haghayegh","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cca.2026.122860_bb0345","article-title":"Biosensors and lateral flow immunoassays: current state and future prospects","volume":"574","author":"Lingadharini","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122860_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.112758","article-title":"A signal enhanced lateral flow immunoassay based on core\u2013shell quantum dots labeled antibody and antigen for sensitive detection of CP4-EPSPS protein","volume":"209","author":"Zeng","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.cca.2026.122860_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2024.136674","article-title":"A label-free strategy for direct detection of Staphylococcus aureus in complex matrixes based on RCA and aptamer","volume":"422","author":"Gan","year":"2025","journal-title":"Sensors Actuators B Chem."},{"issue":"1","key":"10.1016\/j.cca.2026.122860_bb0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ab.2004.07.029","article-title":"On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506)","volume":"334","author":"Murakami","year":"2004","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.cca.2026.122860_bb0365","first-page":"1733","article-title":"Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options","volume":"36","author":"Bieber","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cca.2026.122860_bb0370","unstructured":"Joint Committee for Traceability in Laboratory Medicine (JCTLM), Available: https:\/\/www.jctlm.org, 2026."},{"key":"10.1016\/j.cca.2026.122860_bb0375","series-title":"Measurement Procedure Comparison and Bias Estimation Using Patient Samples, CLSI Guideline EP09c","author":"CLSI","year":"2018"},{"key":"10.1016\/j.cca.2026.122860_bb0380","series-title":"Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory, CLSI Guideline C28-A3c","author":"CLSI","year":"2010"},{"issue":"11","key":"10.1016\/j.cca.2026.122860_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293332","article-title":"Prediction of disease severity using serum biomarkers in patients with mild-moderate atopic dermatitis: a pilot study","volume":"18","author":"Lee","year":"2023","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cca.2026.122860_bb0390","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s13555-025-01481-4","article-title":"Lebrikizumab rapidly lowers inflammatory biomarkers with clinical correlations in moderate-to-severe atopic dermatitis","volume":"15","author":"Guttman-Yassky","year":"2025","journal-title":"Dermatol. Ther. (Heidelb.)"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:39:17Z","timestamp":1790721557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126020425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":78,"alternative-id":["S0009898126020425"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.122860","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical standardization and inter-platform harmonization of immunoassay-based biomarkers in atopic dermatitis: Challenges and a roadmap for clinical laboratory implementation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.122860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122860"}}